T1	CHEM 16 43	carboximetilcelulosa sódica
#1	AnnotatorNotes T1	C0037487; carboxymethylcellulose sodium; Organic Chemical · Pharmacologic Substance
T2	PROC 52 63	tratamiento
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	DISO 68 89	síndrome del ojo seco
#3	AnnotatorNotes T3	C0013238; Dry Eye Syndromes; Disease or Syndrome
T4	PROC 101 120	Evaluar la eficacia
#4	AnnotatorNotes T4	C1707887; Efficacy Study; Research Activity
T5	CHEM 127 154	carboximetilcelulosa sódica
#5	AnnotatorNotes T5	C0037487; carboxymethylcellulose sodium; Organic Chemical · Pharmacologic Substance
T6	PROC 163 174	tratamiento
#6	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	DISO 179 199	Síndrome de Ojo Seco
#7	AnnotatorNotes T7	C0013238; Dry Eye Syndromes; Disease or Syndrome
T8	PROC 242 306	ensayo clínico prospectivo randomizado unicéntrico y enmascarado
T9	CHEM 551 554	CMC
#8	AnnotatorNotes T9	C0037487; carboxymethylcellulose sodium; Organic Chemical · Pharmacologic Substance
T10	DISO 371 374	SOS
#9	AnnotatorNotes T10	C0013238; Dry Eye Syndromes; Disease or Syndrome
T11	PROC 445 467	clínicamente evaluados
T12	CHEM 500 518	solución isotónica
#10	AnnotatorNotes T12	C0022260; Isotonic Solutions; Pharmacologic Substance
T13	CHEM 522 549	carboximetilcelulosa sódica
#11	AnnotatorNotes T13	C0037487; carboxymethylcellulose sodium; Organic Chemical · Pharmacologic Substance
T14	DISO 586 594	síntomas
T15	ANAT 683 694	conjuntival
#12	AnnotatorNotes T15	C0009758; conjunctiva; Body Part, Organ, or Organ Component | C1278888; Entire conjunctiva; Body Part, Organ, or Organ Component
T16	PROC 722 731	protocolo
#13	AnnotatorNotes T16	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T17	DISO 962 976	sintomatología
T18	CHEM 1115 1118	CMC
#14	AnnotatorNotes T18	C0037487; carboxymethylcellulose sodium; Organic Chemical · Pharmacologic Substance
T19	PROC 1099 1110	tratamiento
#15	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	ANAT 1183 1201	superficie corneal
#16	AnnotatorNotes T20	C4514681; Entire corneal surface zone; Body Location or Region
T21	CHEM 1853 1856	CMC
#17	AnnotatorNotes T21	C0037487; carboxymethylcellulose sodium; Organic Chemical · Pharmacologic Substance
T22	CHEM 1633 1636	CMC
#18	AnnotatorNotes T22	C0037487; carboxymethylcellulose sodium; Organic Chemical · Pharmacologic Substance
T23	DISO 1575 1583	síntomas
T24	PROC 1617 1628	tratamiento
#19	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	CHEM 566 569	BSS
#20	AnnotatorNotes T25	C0543134; Balanced salt solution; Pharmacologic Substance · Inorganic Chemical
T26	PROC 1762 1773	tratamiento
#21	AnnotatorNotes T26	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T27	ANAT 81 84	ojo
#22	AnnotatorNotes T27	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T28	ANAT 191 194	Ojo
#23	AnnotatorNotes T28	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T29	PROC 611 653	pruebas objetivas de funcionalidad clínica
T30	PROC 483 491	tratados
#24	AnnotatorNotes T30	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T31	PROC 660 694	citología de impresión conjuntival
#25	AnnotatorNotes T31	C0842248; Examination of eye by impression cytology of cornea; Diagnostic Procedure
T32	ANAT 1073 1090	película lagrimal
T33	ANAT 1227 1244	película lagrimal
T34	PROC 1459 1492	pruebas funcionales de evaluación
T35	PROC 1641 1663	citología de impresión
T36	DISO 1902 1905	SOS
#26	AnnotatorNotes T36	C0013238; Dry Eye Syndromes; Disease or Syndrome
T37	DISO 201 204	SOS
#27	AnnotatorNotes T37	C0013238; Dry Eye Syndromes; Disease or Syndrome
T38	LIVB 345 354	pacientes
#28	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	Duration 414 422	12 meses
T40	LIVB 428 437	pacientes
#29	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	Frequency 468 480	cada 3 meses
T42	Form 500 508	solución
#30	AnnotatorNotes T42	C1382100; Solution Dosage Form; Biomedical or Dental Material
T43	Dose 556 563	al 0,5%
T45	LIVB 1346 1355	pacientes
#31	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	LIVB 1401 1414	grupo control
#32	AnnotatorNotes T46	C0009932; Control Groups; Group
T49	LIVB 330 337	control
#33	AnnotatorNotes T49	C0009932; Control Groups; Group
T50	LIVB 315 329	grupo problema
#34	AnnotatorNotes T50	C2986530; Intervention Group; Population Group (?) | C5205743; Experimental Group; Population Group (?)
T44	LIVB 1291 1305	grupo problema
#35	AnnotatorNotes T44	C2986530; Intervention Group; Population Group (?) | C5205743; Experimental Group; Population Group (?)
T51	LIVB 1362 1376	grupo problema
#36	AnnotatorNotes T51	C2986530; Intervention Group; Population Group (?) | C5205743; Experimental Group; Population Group (?)
T47	Neg_cue 1669 1671	no
T48	CONC 1696 1707	diferencias
A1	Assertion T48 Negated
#37	AnnotatorNotes T48	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T47 Arg2:T48	
T52	Quantifier_or_Qualifier 595 605	subjetivos
#38	AnnotatorNotes T52	C0439655; Subjective observation (qualifier value); Qualitative Concept
T53	Quantifier_or_Qualifier 977 986	subjetiva
#39	AnnotatorNotes T53	C0439655; Subjective observation (qualifier value); Qualitative Concept
#40	AnnotatorNotes T14	C1457887; Symptoms; Sign or Symptom
#41	AnnotatorNotes T17	C1457887; Symptoms; Sign or Symptom
#42	AnnotatorNotes T23	C1457887; Symptoms; Sign or Symptom
T54	Quantifier_or_Qualifier 1584 1594	subjetivos
#43	AnnotatorNotes T54	C0439655; Subjective observation (qualifier value); Qualitative Concept
R2	Used_for Arg1:T1 Arg2:T2	
R3	Location_of Arg1:T27 Arg2:T3	
R4	Used_for Arg1:T5 Arg2:T6	
R5	Location_of Arg1:T28 Arg2:T7	
R6	Location_of Arg1:T28 Arg2:T37	
R7	Experiences Arg1:T38 Arg2:T10	
R8	Experiences Arg1:T49 Arg2:T10	
R9	Experiences Arg1:T50 Arg2:T10	
R10	Has_Duration_or_Interval Arg1:T8 Arg2:T39	
T55	Quantifier_or_Qualifier 375 379	leve
#44	AnnotatorNotes T55	C2945599; Mild (qualifier value); Qualitative Concept
R11	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T55	
T56	Quantifier_or_Qualifier 382 390	moderado
#45	AnnotatorNotes T56	C0205081; Moderate (severity modifier); Qualitative Concept
R12	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T56	
#46	AnnotatorNotes T11	C4084924; Clinical Evaluation; Health Care Activity
R13	Has_Frequency Arg1:T11 Arg2:T41	
R14	Experiences Arg1:T40 Arg2:T11	
R15	Experiences Arg1:T40 Arg2:T30	
R16	Has_Drug_Form Arg1:T12 Arg2:T42	
R17	Used_for Arg1:T12 Arg2:T30	
R18	Combined_with Arg1:T12 Arg2:T13	
R19	Combined_with Arg1:T12 Arg2:T9	
R20	Combined_with Arg1:T12 Arg2:T25	
R21	Has_Dose_or_Strength Arg1:T9 Arg2:T43	
R22	Has_Dose_or_Strength Arg1:T13 Arg2:T43	
R23	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T52	
R24	Location_of Arg1:T15 Arg2:T31	
T57	CONC 842 864	prueba de chi cuadrado
#47	AnnotatorNotes T57	C0008041; Ch-Square Test; Intellectual Product
T58	CONC 866 868	χ2
#48	AnnotatorNotes T58	C0008041; Ch-Square Test; Intellectual Product
R25	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T53	
T59	Observation 1002 1009	mejoría
#49	AnnotatorNotes T59	C0184511; Improved; Finding (?)
R26	Overlap Arg1:T17 Arg2:T59	
R27	Used_for Arg1:T18 Arg2:T19	
R28	Location_of Arg1:T32 Arg2:T59	
R29	After Arg1:T59 Arg2:T19	
T61	Observation 1144 1151	mejoría
#51	AnnotatorNotes T61	C0184511; Improved; Finding (?)
T62	CONC 1165 1176	humectación
#52	AnnotatorNotes T62	C0162598; Wettability; Qualitative Concept
R30	Location_of Arg1:T20 Arg2:T62	
T63	CONC 1210 1220	integridad
#53	AnnotatorNotes T63	C1947912; Integrity; Qualitative Concept
R31	Location_of Arg1:T33 Arg2:T63	
T64	Observation 1276 1284	mejorías
#54	AnnotatorNotes T64	C0184511; Improved; Finding (?)
R32	Experiences Arg1:T44 Arg2:T64	
R33	Experiences Arg1:T44 Arg2:T61	
R37	Experiences Arg1:T45 Arg2:T34	
R38	Experiences Arg1:T51 Arg2:T34	
R39	Experiences Arg1:T46 Arg2:T34	
R40	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T54	
T67	Quantifier_or_Qualifier 1595 1608	concomitantes
#57	AnnotatorNotes T67	C0521115; Simultaneous; Temporal Concept
R41	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T67	
R43	Used_for Arg1:T22 Arg2:T24	
T68	Observation 1741 1773	respuesta clínica al tratamiento
#58	AnnotatorNotes T68	C1319171; Medication response; Finding
R44	Overlap Arg1:T68 Arg2:T26	
T69	Observation 1863 1870	mejoría
#59	AnnotatorNotes T69	C0184511; Improved; Finding (?)
R45	Causes Arg1:T21 Arg2:T69	
T70	Quantifier_or_Qualifier 1906 1910	leve
#60	AnnotatorNotes T70	C2945599; Mild (qualifier value); Qualitative Concept
R46	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T70	
T71	CONC 1878 1897	parámetros clínicos
T72	Quantifier_or_Qualifier 1913 1921	moderado
#61	AnnotatorNotes T72	C0205081; Moderate (severity modifier); Qualitative Concept
R47	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T72	
T73	Observation 1811 1817;1837 1846	efecto favorable
R48	Causes Arg1:T21 Arg2:T73	
T74	Quantifier_or_Qualifier 1708 1722	significativas
A2	Assertion T74 Negated
#62	AnnotatorNotes T74	C0750502; Significant; Idea or Concept
R49	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T74	
R50	Negation Arg1:T47 Arg2:T74	
R42	After Arg1:T23 Arg2:T24	
#50	AnnotatorNotes T73	C4049461; Unexpected beneficial therapeutic response; Finding (?)
#55	AnnotatorNotes T35	C5555889; Impression Cytology; Laboratory Procedure
A3	Experiencer T50 Patient
A4	Experiencer T49 Patient
A5	Experiencer T38 Patient
A6	Experiencer T40 Patient
A7	Experiencer T44 Patient
A8	Experiencer T45 Patient
A9	Experiencer T51 Patient
A10	Experiencer T46 Patient
